Keywords: کلینیک بارسلون سرطان کبد; Hepatic artery embolization; learning curve; hepatocellular carcinoma; operator experience; TAE; Transarterial hepatic embolization; TACE; Transarterial chemoembolization; HCC; Hepatocellular carcinoma; OS; Overall survival; TLP; Time to local tumor progr
مقالات ISI کلینیک بارسلون سرطان کبد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کلینیک بارسلون سرطان کبد; Liver Cancer; Screening; Early Detection; Curative Treatment; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IPCW; inverse probability of censoring weighted; IQR
Keywords: کلینیک بارسلون سرطان کبد; Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LR; liver resection; LT; liver transplantation; OS; overall survival;
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolics; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: کلینیک بارسلون سرطان کبد; ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CTCAE; Common Terminology Criteria for Adverse Events; HCC; hepatocellular carcinoma; OR; odds ratio; PES; postembolization syndrome;
Keywords: کلینیک بارسلون سرطان کبد; Liver Cancer; Risk Factors; Prognosis; Predicted Outcome; BCLC; Barcelona Clinic Liver Cancer; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HKLC; Hong Kong Liver Cancer; IAT; intr
Keywords: کلینیک بارسلون سرطان کبد; HCC, hepatocellular carcinoma; OS, overall survival; C-P, Child-Pugh; ALBI, albumin-bilirubin; BCLC, Barcelona Clinic Liver Cancer; AFP, α-fetoproteinHepatocellular carcinoma; Barcelona Clinic Liver Cancer; Overall survival; Albumin-bilirubin score; Curat
Keywords: کلینیک بارسلون سرطان کبد; ALBI; albumin-bilirubin; BCLC; Barcelona Clinic Liver Cancer; C-P; Child-Pugh; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS; median overall survival; 90Y; yttrium-90;
Keywords: کلینیک بارسلون سرطان کبد; 1H NMR; proton nuclear magnetic resonance; AFP; alpha-fetoprotein; ALT; alanine transaminase; BCLC; Barcelona Clinic Liver Cancer; BMI; body mass index; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HIV; human immunodefici
Keywords: کلینیک بارسلون سرطان کبد; Liver Cancer; Fatty Liver; NASH; Steatosis; AFP; alpha-fetoprotein; APRI; aspartate aminotransferase to platelet ratio; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; EMR; electronic medical record; HBV; hepatitis B virus; HCC; hepatocellul
Keywords: کلینیک بارسلون سرطان کبد; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: کلینیک بارسلون سرطان کبد; Outcome; Liver Cancer; Therapy; Hepatic; AUROC; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HAP; hepatic arterial embolization prognostic; HCC; hepatocellular carcinoma; HR; hazard ratio; mHAP; modified hepatic arterial embolization prog
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; BCLB; Barcelona Clinic Liver Cancer; LRT; loco-regional therapy; BCT; best supportive care; MS; median survival; PST; performance status; ECOG; Easter Cooperative Oncology Group; CRPH; clinically relevant portal hypertension
Keywords: کلینیک بارسلون سرطان کبد; HCC; Hepatocellular carcinoma; HBV; Hepatitis B virus infection; HCV; Hepatitis C virus infection; US; Ultrasound; AFP; Alpha-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; RFA; Radiofrequency ablation; TACE; Transarterial chemoembolization; TARE; Tr
Keywords: کلینیک بارسلون سرطان کبد; AFP; α-fetoprotein; AST; aspartate aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CLIP; Cancer of the Liver Italian Program; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; IQR; interquartile range; PEIT; percutane
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; AJCC; American Joint Committee on Cancer; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; JIS; Japan Integrated Staging; CUPI; Chinese University Prognos
Keywords: کلینیک بارسلون سرطان کبد; Liver Cancer; NASH; Incidence; Time; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CPT; Common Procedural Terminology; EMR; electronic medical records; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepati
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Gadoxetic Acid; Liver Cancer; Combined Image Analyses; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CT; computed tomography; HCC; hepatocellular carcinoma; HR; hazard ratio; IPTW; inverse probability treatment weighting; MR; magneti
Keywords: کلینیک بارسلون سرطان کبد; AFP; α-fetoprotein; AUC; area under the curve; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; IL; interleukin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NLR; neutrophil-to-lymphocyte ratio; RE; radioembolization
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; MELD; Model for End-stage Liver Disease;
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; TTP; time to progression; NTUH; National Taiwan University Hospital; OS; overall survival; BCLC; Barcelona Clinic Liver Cancer; CLIP; Cancer of the Liver Italian Program; ECOG PS; Eastern Cooperative Oncology Group performan
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; PLC; primary liver cancer; HR; hepatic resection; LT; liver transplantation; US; ultrasound; EASL; European Association for the Study of the Liver; EORTC; European Organization for Research and Trea
Keywords: کلینیک بارسلون سرطان کبد; ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HR; hazard ratio;
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; RFA; radiofrequency ablation; PEI; percutaneous ethanol injection; TACE; transarterial chemoembolization; BCLC; Barcelona Clinic Liver Cancer; 125I; iodine-125; CT; computed tomography; MR; magnetic resonance; OS; overall su
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; PVT; portal vein thrombosis; ROI; region of interest; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; TD; t
Keywords: کلینیک بارسلون سرطان کبد; AFP; α-fetoprotein; AIC; Akaike information criterion; BCLC; Barcelona Clinic Liver Cancer; C-index; concordance index; CLIP; Cancer of the Liver Italian Program; CTP; Child-Turcotte-Pugh; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular car
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CI; 95% confidence interval; CP; Child-Pugh; CT; computed tomography; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy; MRI; magnetic resonance imaging;
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; RFA; radiofrequency ablation; PEI; percutaneous ethanol injection; TACE; transarterial chemoembolization; BCLC; Barcelona Clinic Liver Cancer; AEs; adverse events; INR; International Normalized Ratio; MELD; Model for End-Sta
Keywords: کلینیک بارسلون سرطان کبد; sCD163; soluble CD163; HCC; hepatocellular carcinoma; OS; overall survival; AFP; alpha-fetoprotein; CLIP; Cancer of the Liver Italian Program; BCLC; Barcelona Clinic Liver Cancer; CRP; C-reactive protein; NASH; non-alcoholic steatohepatitis; CK; cytokerat
Keywords: کلینیک بارسلون سرطان کبد; ADME; absorption distribution metabolism and excretion; AFP; alpha-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; Chk 1; check point 1; HBV; Hepatitis B Virus; HCC; hepatocellular carcinoma; HCV; Hepatitis C Virus; LT; liver transplatation; NAFLD; nona
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era
Keywords: کلینیک بارسلون سرطان کبد; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; IQR; interquartile range; HR; hazard ratio; AHR; adjusted hazard ratio; CTP; Child-Turcotte-Pugh; PS; performance status; ECOG; Eastern Cooperative Oncology Group; BCLC; Barcelona Clinic Liver Cancer;
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study
Keywords: کلینیک بارسلون سرطان کبد; Early hepatocellular carcinoma; Microvascular invasion; HBeAg; Hepatectomy; Survival; HCC; hepatocellular carcinoma; TNM; Tumor-Node-Metastasis; BCLC; Barcelona clinic liver cancer; RFS; recurrence-free survival; OS; overall survival; ALT; alanine aminotr
Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CTP; Child-Turcotte-Pugh; ECOG; Eastern Cooperative Oncology Group; HCC; heptaocellular carcinoma; MVI; macrovascular invasion; SOR; sorafenib;
Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C
Keywords: کلینیک بارسلون سرطان کبد; CS; Complement System; C7; Complement Component 7; MAC; Membrane Attack Complex; HCC; Hepatocellular Carcinoma; PCR; Polymerase Chain Reaction; OR; Odds Ratio; CI; Confidence Interval; HCV; Hepatitis C Virus; SNP; Single Nucleotide Polymorphism; RNA; Ribo
Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma
Keywords: کلینیک بارسلون سرطان کبد; AUROC; Area Under Receiver Operator Characteristic Curve; BCLC; Barcelona Clinic Liver Cancer; HCC; Hepatocellular Carcinoma; ICG; Indocyanine Green; LF; Liver Failure; MELD; model For End Stage Liver Disease; PDR; Plasma Disappearance Rate; TACE; Trans-a
Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-An immunohistochemical study
Keywords: کلینیک بارسلون سرطان کبد; HCC; hepatocellular carcinoma; AFLD; alcohol-induced fatty liver disease; NAFLD; non-alcoholic fatty liver disease; Vh; viral hepatitis; ZIP; Zrt-Irt-like protein; ZnT; Zinc transporter protein; BCLC; Barcelona Clinic Liver Cancer; Hepatitis; Hepatocellul
Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices
Keywords: کلینیک بارسلون سرطان کبد; ALBI; albumin-bilirubin; ALBI-PLT score; albumin-bilirubin grade and platelet count; BCLC; Barcelona Clinic Liver Cancer; CTP; Child-Turcotte-Pugh; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HRV; high-risk esophageal va
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Keywords: کلینیک بارسلون سرطان کبد; RESIST-HCV; Liver Cancer Risk; Reduction; Sofosbuvir; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DAAs; direct-antiviral agents; EGS; esophageal gastroscopy; EV; esophageal varices; HCC; hepatocellular carcinoma; HCV; hepatitis C virus;
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
Keywords: کلینیک بارسلون سرطان کبد; Diagnosis; Hepatocellular carcinoma; miR-122; miR-224; Sensitivity; ADAM17; A disintegrin and metalloprotease domain-containing protein 17; AFP; Alpha-fetoprotein; AKT; AKT/Protein kinase B; ALP; Alkaline phosphatase; ALT; Alanine aminotransferase; ANOVA;
Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; ORR; overall res
Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; RF; radiofrequency; SEER; Surveillance, Epidemiology, and End Results [database];
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma
Keywords: کلینیک بارسلون سرطان کبد; ABCR; α-fetoprotein, Barcelona Clinic Liver Cancer, Child-Pugh, and response [score]; AFP; α-fetoprotein; ART; Assessment for Retreatment with Transarterial Chemoembolization [score]; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; EASL;
Original articleBetter prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C
Keywords: کلینیک بارسلون سرطان کبد; antiviral therapy; Barcelona Clinic Liver Cancer; hepatic resection; hepatitis B virus; hepatocellular carcinoma;
Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; DEE; drug-eluting embolic; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; IDR; intrahepatic distant recurrence; LTP; local tumor progression; PFS; progression-free survi
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication
Keywords: کلینیک بارسلون سرطان کبد; HCV; hepatitis C virus; pegIFN-α; pegylated interferon alpha; DAAs; direct acting antivirals; BCLC; Barcelona ClÃnic Liver Cancer; IF; immunofluorescence; HCVpp; HCV pseudoparticles; HCVcc; HCV cell culture; JFH1; Japanese fulminant hepatitis 1; Apo; ap
Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; CLM; colorectal carcinoma liver metastases; CRC; colorectal carcinoma; DEBIRI; drug-eluting beads loaded with irinotecan; DEE; drug-eluting embolic; ECOG; Eastern Cooperative Oncology Group; GM-CSF; granulocyte-macroph
Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma
Keywords: کلینیک بارسلون سرطان کبد; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; TARE; transarterial radioembolization; 90Y; yttrium-90;
Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study
Keywords: کلینیک بارسلون سرطان کبد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; OS; overall survival; RECIST; Response Evaluation Criteria In Solid Tumors;